close
Add to watchlist
Orchid Cellmark Inc (ORCH) Healthcare, Biotechnology & Drugs
Orchid Cellmark Inc., together with its subsidiaries, provides DNA testing services in the United States and the United Kingdom. Its services generate genetic profile information by analyzing an organism's genetic identity. The company focuses on DNA testing primarily for human identity and agricultural applications. It offers forensic DNA, family relationship testing, government and private paternity testing, security, and immigration and other DNA testing services to government agencies, commercial companies, and private individuals. The company also provides agricultural DNA testing services for selective trait breeding; agricultural susceptibility testing to enable farmers to breed sheep resistant to degenerative diseases that affect the nervous systems of sheep and goats; and genetic marker analysis in animals to confirm relationships to members of the agricultural community. Orchid Cellmark was founded in 1995 and is headquartered in Princeton, New Jersey.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 2.79 |
| Volume | 0 |
| Volume Avg | 59658 |
| 52 Week High | 2.81 |
| 52 Week Low | 1.70 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.22 |
| EPS change Q/Q | -50% |
| EPS change Q/Q Yr ago | 1000% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -66.67% |
| REV change Q/Q | -4.05% |
| REV change Q/Q Yr ago | 5.73% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |
